| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 7 Feb 2025 | 3 Feb 2025 |
| WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and is closure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 7th February 2025 inter-alia to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December 2024. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2024-25/086 dated 3rd February, 2025, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 7th February, 2025, inter-alia, have approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2024. (As Per BSE Announcement Dated on: 07/02/2025) | ||
| Board Meeting | 13 Nov 2024 | 8 Nov 2024 |
| WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 13th November 2024 inter-alia to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the half year ended 30th September 2024. In view of the above the trading window for dealing in the shares of the Company which was closed from Tuesday 1st October 2024 shall remain closed until 48 hours after the declaration of financial results on 13th November 2024. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we enclose herewith Unaudited Financial Results for the quarter and half year .... Read More.. (As Per BSE Announcement Dated on 13.11.2024) | ||
| Board Meeting | 9 Aug 2024 | 5 Aug 2024 |
| WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 9th August 2024 inter-alia to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2024. Pursuant to Regulation 30 of SEBI LODR Regulations, 2015 , we wish to inform that the Board of Directors at its meeting held today i.e. 9th August, 2024 have approved the appointment of Mr. Paresh Kajrolkar, Head of the Internal Audit, based on the recommendation of Audit Committee as Internal Auditor of the Company w.e.f. 9th August, 2024. Pursuant to Regulations 30 of SEBI LODR Regulations, 2015 and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2024-25/032 dated 5th August, 2024, we wish to inform .... Read More.. Pursuant to Regulations 30 of SEBI LODR Regulations, 2015 and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2024-25/032 dated 5th August, 2024, we wish to inform .... Read More.. (As per BSE Announcement Dated on 09/08/2024) | ||
| Board Meeting | 28 May 2024 | 21 May 2024 |
| WOCKHARDT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 28th May 2024 inter-alia to consider and approve the following: (i) the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended 31st March 2024; and (ii) raising of funds by various methods as may be permitted under applicable law subject to consent of shareholder at the ensuing Annual General Meeting and such approvals and compliances as may be required and to approve ancillary actions for the above mentioned fund raising. Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, We wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. May, 28, 2024 have approved the matters as attached in the PDF. Pursuant to Regulation 30 of SEBI(Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 28th May 2024 approved the the Appointment of M/s. M S K C & Associates, Chartered Accountant as Statutory Auditors o the Company for a period of 5 years with effect from conclusion of forthcoming Annual General Meeting. (As Per BSE Announcement dated on 28.05.2024) | ||
WCK 6777 is the only once-a-day antibiotic in the global pipeline designated for outpatient parenteral antimicrobial therapy (OPAT).
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
